Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by The Wistar Institute

Wistar Institute Researchers Discover New Combination Therapy Approach for Metastatic Ovarian Cancer
From The Wistar Institute
Via GlobeNewswire
Wistar Institute Researchers Identify Parkinson-related Protein’s Role in Cancer and T Cell Activation
From The Wistar Institute
Via GlobeNewswire
Award-Winning Biotech Training Program Connects Philadelphians with Quality Jobs in the Region’s Rapidly Growing Life Sciences Sector
From The Wistar Institute
Via GlobeNewswire
The Wistar Institute Launches HIV Cure and Viral Diseases Center
From The Wistar Institute
Via GlobeNewswire
The Wistar Institute Awarded Second National Science Foundation Grant to Expand Award-winning STEM Training Program
From The Wistar Institute
Via GlobeNewswire
Promising Personalized Approach to Liver Cancer Therapy Made Possible by DNA-based Neoantigen Research Designed at The Wistar Institute
From The Wistar Institute
Via GlobeNewswire
PCOM, The Wistar Institute Announce Cancer Biology Graduate Program
From The Wistar Institute
Via GlobeNewswire
Wistar Scientists Engineer New NK cell Engaging Immunotherapy Approaches to Target and potentially Treat recalcitrant Ovarian Cancer
From The Wistar Institute
Via GlobeNewswire
Award-Winning Biotech Training Program to Begin Recruitment with New Employer Partner in Life Sciences
From The Wistar Institute
Via GlobeNewswire
Wistar Researchers Discover Potential Target for Gastric Cancers Associated with Epstein-Barr Virus
From The Wistar Institute
Via GlobeNewswire
New Community Partnership Model Boosts Participant Inclusion into HIV Cure-Directed Research
From The Wistar Institute
Via GlobeNewswire
Wistar-Led Team Awarded More Than $12 Million Grant from the NCI to Investigate Link Between Epstein-Barr Virus and Carcinomas
From The Wistar Institute
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.